Designing and computational analyzing of chimeric long-lasting #GLP-1 receptor agonists for type 2 #diabetes
https://2medical.news/2023/11/06/designing-and-computational-analyzing-of-chimeric-long-lasting-glp-1-receptor-agonists-for-type-2-diabetes/
https://2medical.news/2023/11/06/designing-and-computational-analyzing-of-chimeric-long-lasting-glp-1-receptor-agonists-for-type-2-diabetes/
2Medical.News
Designing and computational analyzing of chimeric long-lasting #GLP-1 receptor agonists for type 2 #diabetes
Glucagon-like peptide-1 (GLP-1) is an intestinally derived incretin that plays a vital role in engineering the biological circuit involved in treating type 2 diabetes. Exceedingly short half-life (…
Most #GLP-1 Medications Correlated with a Lower Likelihood of #Anxiety and #Depression Diagnoses
https://2medical.news/2024/02/21/most-glp-1-medications-correlated-with-a-lower-likelihood-of-anxiety-and-depression-diagnoses/
https://2medical.news/2024/02/21/most-glp-1-medications-correlated-with-a-lower-likelihood-of-anxiety-and-depression-diagnoses/
2Medical.News
Most #GLP-1 Medications Correlated with a Lower Likelihood of #Anxiety and #Depression Diagnoses
Key FindingsDiabetic patients prescribed tirzepatide, semaglutide, dulaglutide, and exenatide are less likely to be diagnosed with depression after starting the medication compared to those not on …